“…The mechanisms underlying this hourglass-like process are still debated, but animal research suggests that it arises from a use-dependent local augmentation of sleep-promoting substances (adenosine (Basheer et al, 2004) and cytokines (Krueger, 2008)), from an increase in extracellular glutamate level (Dash et al, 2009), and/or from an experience-dependent increase of average brain synaptic strength, excitability and size during wakefulness (Vyazovskiy et al, 2008; Bushey et al, 2011). Other molecular markers of sleep loss have been identified in rodents (Franken and Dijk, 2009), while human polymorphisms have been associated with difference in sleep regulation [e.g., PERIOD3 (PER3) (Viola et al, 2007) , Adenosine Deaminase (ADA) , Adenosin A2a receptor (ADORA2A), Brain Derived Neurotrophic Factor (BDNF), Catechol-O-Methyltransferase (COMT) , human leukocyte antigen (HLA) , (Goel and Dinges, 2011), dopamine transporter (DA) , (Valomon et al, 2014), ABCC9 (Allebrandt et al, 2013); for review see (Landolt, 2011)]. At the macroscopic scale, the electroencephalogram (EEG) provides the best established markers of sleep need and intensity: slow wave activity (SWA; 0.5–4 Hz) during Non-Rapid Eye Movement (NREM) sleep (Dijk et al, 1987, 1997), and theta activity (4–8 Hz) during wakefulness (Cajochen et al, 2002).…”